Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats

被引:150
作者
Bhatt, Siddhartha R. [1 ]
Lokhandwala, Mustafa F. [1 ]
Banday, Anees Ahmad [1 ]
机构
[1] Univ Houston, Heart & Kidney Inst, Coll Pharm, 4800 Calhoun,S&R-2 Bldg,Rm 453A, Houston, TX 77204 USA
关键词
Vasorelaxation; Superoxide; Oxidative stress; L-Arginine; Nitrotyrosine; VASCULAR OXIDATIVE STRESS; RED WINE; NAD(P)H OXIDASE; UP-REGULATION; EXPRESSION; DYSFUNCTION; SUPEROXIDE; RELAXATION; PRESSURE; RECEPTOR;
D O I
10.1016/j.ejphar.2011.05.026
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Endothelial dysfunction is a hallmark of hypertension and vascular oxidative stress can contribute to endothelial dysfunction and hypertension development. Resveratrol is an antioxidant polyphenol which improves endothelium dependent relaxation, the mechanisms of which are unknown. Also, the role of resveratrol in hypertension remains to be established. The purpose of this study was to investigate the mechanisms of resveratrol induced improvement of endothelial function and establish its role in hypertension. SHR and WKY rats, 3-4 weeks old, were treated with resveratrol in drinking water for 10 weeks, untreated SHR and WKY rats served as controls. At the end of the treatment, control SHR exhibited increased blood pressure, oxidative stress and attenuated endothelium dependent relaxation in comparison to WKY rats. The impaired endothelium function in SHR was associated with lower nitrite/nitrate levels, elevated nitrotyrosine content and eNOS uncoupling. Resveratrol treatment attenuated hypertension development in SHR as indicated by lower blood pressure in resveratrol treated SHR (SHR-R) compared to control SHR. SHR-R also exhibited reduced H2O2 content and elevated superoxide dismutase activity. Resveratrol treatment normalized endothelium dependent vasorelaxation in SHR. In parallel, resveratrol restored nitrite/nitrate levels and normalized nitrotyrosine content in SHR. SHR exhibited increased L-arginine dependent superoxide production which was blocked by NOS inhibitor L-NNA, suggesting eNOS uncoupling. eNOS uncoupling was prevented by resveratrol treatment. In conclusion, early treatment with resveratrol lowers oxidative stress, preserves endothelial function and attenuates development of hypertension in SHR. More importantly, prevention of eNOS uncoupling and NO scavenging could represent novel mechanisms for resveratrol-mediated antihypertensive effects. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 40 条
[1]
Mechanisms of oxidative stress-induced increase in salt sensitivity and development of hypertension in Sprague-Dawley rats [J].
Banday, Anees Ahmad ;
Muhammad, Abdul Bari ;
Fazili, Fatima Rizwan ;
Lokhandwala, Mustafa .
HYPERTENSION, 2007, 49 (03) :664-671
[2]
Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[3]
Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects [J].
Bernatova, Iveta ;
Victoria Conde, M. ;
Kopincova, Jana ;
Carmen Gonzalez, M. ;
Puzserova, Angelika ;
Arribas, Silvia M. .
JOURNAL OF HYPERTENSION, 2009, 27 :S27-S31
[4]
Biological effects of resveratrol [J].
Bhat, KPL ;
Kosmeder, JW ;
Pezzuto, JM .
ANTIOXIDANTS & REDOX SIGNALING, 2001, 3 (06) :1041-1064
[5]
Bhatt S, 2009, FASEB J, V23, pLB53
[6]
Possible Role of Oxidative Stress in the Pathogenesis of Hypertension [J].
Ceriello, Antonio .
DIABETES CARE, 2008, 31 :S181-S184
[7]
Chen CK, 1996, GEN PHARMACOL-VASC S, V27, P363
[8]
Chen HI., 1997, AM J PHYSIOL, V273, P1816
[9]
Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988-1994 and 1999-2004 [J].
Cutler, Jeffrey A. ;
Sorlie, Paul D. ;
Wolz, Michael ;
Thom, Thomas ;
Fields, Larry E. ;
Roccella, Edward J. .
HYPERTENSION, 2008, 52 (05) :818-827
[10]
DOROK J, 2001, EXP CLIN CARDIOL, V6, P142